Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden

Annals of the Rheumatic Diseases

Volumn 74, Issue 6, 2015, Pages 993-997

  Mohammad, Aladdin J ^a,b   Nilsson, Jan Åke ^a,b   Jacobsson, Lennart T H ^a,c   Merkel, Peter A ^d   Turesson, Carl ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTUMN; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC DISTRIBUTION; GIANT CELL ARTERITIS; HEREDITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; SEASONAL VARIATION; SEX DIFFERENCE; SPRING; SUMMER; SURVIVAL RATE; SURVIVAL TIME; SWEDEN; WINTER; BIOPSY; METABOLISM; MIDDLE AGED; PATHOLOGY; SEASON; TEMPORAL ARTERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; GIANT CELL ARTERITIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEASONS; SWEDEN; TEMPORAL ARTERIES;

EID: 84934921991     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204652     Document Type: Article

References (31)

1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1-11.
2. Berger CT, Wolbers M, Meyer P, et al. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology (Oxford) 2009;48:258-61.
3. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162-7.
4. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 2012;11:6-7.
5. Danesh-Meyer H, Savino PJ, Gamble GG. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology 2005;112:1098-103.
6. Miller NR. Visual manifestations of temporal arteritis. Rheum Dis Clin North Am 2001;27:781-97, vi.
7. Petursdottir V, Johansson H, Nordborg E, et al. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford) 1999;38:1208-12.
8. Salvarani C, Crowson CS, O'Fallon WM, et al. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004;51:264-8.
9. Salvarani C, Macchioni P, Zizzi F, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 1991;34:351-6.
10. Bas-Lando M, Breuer GS, Berkun Y, et al. The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 2007;25(1 Suppl 44):S15-17.
11. Abdul-Rahman AM, Molteno AC, Bevin TH. The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis. N Z Med J 2011;124:44-52.
12. Nordborg C, Nordborg E, Petursdottir V. Giant cell arteritis. Epidemiology, etiology and pathogenesis. APMIS 2000;108:713-24.
13. Crow RW, Katz BJ, Warner JE, et al. Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci 2009;64:365-9.
14. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989;299:549-50.
15. Matteson EL, Gold KN, Bloch DA, et al. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193-6.
16. Bisgard C, Sloth H, Keiding N, et al. Excess mortality in giant cell arteritis. J Intern Med 1991;230:119-23.
17. Ninan J, Nguyen AM, Cole A, et al. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study. J Rheumatol 2011;38:2215-7.
18. Statistics Sweden. http://www.scb.se. Last accessed May 2013.
19. Noltorp S, Svensson B. High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community. Clin Exp Rheumatol 1991;9:351-5.
20. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum 1981;24:899-904.
21. Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 1996;23:112-19.
22. Baldursson O, Steinsson K, Bjornsson J, et al. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 1994;37:1007-12.
23. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94. J Rheumatol 1997;24:1739-43.
24. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983;26:1214-19.
25. Pamuk ON, Donmez S, Karahan B, et al. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Clin Exp Rheumatol 2009;27:830-3.
26. Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, et al. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine 2007;86:61-8.
27. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol 1992;19:273-6.
28. Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006;65:1093-8.
29. Nordborg C, Johansson H, Petursdottir V, et al. The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population. Rheumatology (Oxford) 2003;42:549-52.
30. Uddhammar A, Eriksson AL, Nystrom L, et al. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002;29:737-42.
31. Ezeonyeji AN, Borg FA, Dasgupta B. Delays in recognition and management of giant cell arteritis: results from a retrospective audit. Clin Rheumatol 2011;30:259-62.